You have 9 free searches left this month | for more free features.

Hepatocellular carcinoma (HCC)

Showing 1 - 25 of 9,731

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hepatocellular Carcinoma, Hepatocellular Carcinoma Non-resectable, Liver Cancer Trial (EYE90 Microspheres Treatment)

Not yet recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • EYE90 Microspheres Treatment
  • (no location specified)
Jul 12, 2023

Early Diagnosis of Hepatocellular Carcinoma (HCC)

Recruiting
  • HCC
  • +4 more
  • Biomarker dosage
  • Castellana Grotte, Bari, Italy
    RCCS "Saverio de Bellis"
Mar 23, 2023

Hepatocellular Carcinoma Non-resectable Trial in Belgium, Germany, Italy (BioPearl™)

Not yet recruiting
  • Hepatocellular Carcinoma Non-resectable
  • BioPearl™
  • Brussels, Belgium
  • +5 more
Jun 20, 2023

Unresectable Hepatocellular Carcinoma (HCC) Trial in Milano, Rozzano, Barcelona (NMS-01940153E)

Recruiting
  • Unresectable Hepatocellular Carcinoma (HCC)
  • Milano, Italy
  • +2 more
Dec 2, 2022

Adjuvant Therapy in Patients With Hepatocellular Carcinoma (HCC) at High Risk of Recurrence After Curative Resection or Ablation

Recruiting
  • Adjuvant Therapy in Patients With Hepatocellular Carcinoma (HCC) at High Risk of Recurrence After Curative Resection or Ablation
  • Shanghai, Shanghai, China
    Zhongshan Hospital, Fudan University
Jan 4, 2023

Hepatocellular Carcinoma Trial in Munich, Würzburg (durvalumab, tremelimumab, bevacizumab)

Recruiting
  • Hepatocellular Carcinoma
  • durvalumab, tremelimumab, bevacizumab
  • Munich, Germany
  • +2 more
May 3, 2023

Hepatocellular Carcinoma, Hepatocellular Cancer, Metastatic Hepatocellular Carcinoma Trial run by the NCI (Cyclophosphamide,

Recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Hepatocellular Carcinoma Trial (Livmoniplimab, Budigalimab, Durvalumab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • (no location specified)
Oct 26, 2023

Hepatocellular Carcinoma (HCC) Trial in Taiwan (Chidamide, Regorafenib)

Recruiting
  • Hepatocellular Carcinoma (HCC)
  • Kaohsiung, Taiwan
  • +4 more
Mar 14, 2023

Radiomics, Hepatocellular Carcinoma (HCC), Transcatheter Arterial Chemoembolization (TACE) Trial in Guangzhou (Sorafenib,

Active, not recruiting
  • Radiomics
  • +4 more
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun Yat-sen University
Jun 5, 2023

Hepatocellular Carcinoma (HCC) Trial (Durvalumab, Bevacizumab, Transarterial Radioembolization (TARE))

Not yet recruiting
  • Hepatocellular Carcinoma (HCC)
  • (no location specified)
Sep 11, 2023

Hepatocellular Carcinoma Trial (AK112)

Not yet recruiting
  • Hepatocellular Carcinoma
  • (no location specified)
Jun 24, 2022

Hepatocellular Carcinoma Trial in Roma (multimodal ultrasound)

Recruiting
  • Hepatocellular Carcinoma
  • multimodal ultrasound
  • Roma, Italy
    Fondazione Policlinico Gemelli IRCCS
Aug 3, 2023

HepaSphere Drug-eluting Bead Transarterial Chemoembolization

Recruiting
  • Advanced Hepatocellular Carcinoma (HCC)
  • DEB-TACE plus HAIC or HAIC alone
  • Beijing, Beijing, China
    Beijing Cancer Hospital
May 19, 2023

Hepatocellular Carcinoma Trial in Shanghai (Ori-C101)

Recruiting
  • Hepatocellular Carcinoma
  • Ori-C101
  • Shanghai, China
    Zhongshan Hospital Fudan University
Dec 21, 2022

Chronic Liver Disease, Hepatocellular Carcinoma (HCC) Trial in Toronto (13C Sodium Octanoate)

Terminated
  • Chronic Liver Disease
  • Hepatocellular Carcinoma (HCC)
  • 13C Sodium Octanoate
  • Toronto, Ontario, Canada
    Toronto General Hospital
Dec 19, 2022

ALBI and PALBI Scores and HCC Prognosis

Completed
  • Hepatocellular Carcinoma (HCC) Prognosis
  • ALBI
  • Sohag, Egypt
    Sohag University
Jan 30, 2023

Systemic Therapies for Hepatocellular Carcinoma(HCC)

Enrolling by invitation
  • Hepatocellular Carcinoma Non-resectable
  • Effect of Drug
  • radiological evaluation
  • Wenzhou, Zhejiang, China
    Gang Chen
Sep 14, 2022

Hepatocellular Carcinoma Trial in Heidelberg (Carbon Ion Radiotherapy)

Terminated
  • Hepatocellular Carcinoma
  • Carbon Ion Radiotherapy
  • Heidelberg, Germany
    University Hospital of Heidelberg, Radiation Oncology
Nov 2, 2022

Detect and Expunge Concealed Tumors of the Liver

Recruiting
  • Liver Cancer
    • Hanoi, Vietnam
      108 Military Central Hospital
    Nov 15, 2023

    Hepatocellular Carcinoma Trial in United States (Y-90 TARE, Atezolizumab, Bevacizumab)

    Recruiting
    • Hepatocellular Carcinoma
    • Y-90 TARE
    • +2 more
    • Washington, District of Columbia
    • +5 more
    Jan 18, 2023

    HCC, Liver Cirrhosis Trial (sequential adult left lateral lobe liver transplantation (SALT))

    Not yet recruiting
    • HCC
    • Liver Cirrhosis
    • sequential adult left lateral lobe liver transplantation (SALT)
    • (no location specified)
    Oct 3, 2023

    Hepatocellular Carcinoma Non-resectable, Metastatic Colorectal Cancer, Liver Cancer Trial in Grafton (Eye90 Microspheres)

    Recruiting
    • Hepatocellular Carcinoma Non-resectable
    • +2 more
    • Eye90 Microspheres
    • Grafton, New Zealand
      Auckland District Health Board
    Jan 30, 2023

    Advanced Hepatocellular Carcinoma (HCC), Gastric Cancer Metastatic to Liver, Colorectal Cancer Metastatic to Liver Trial in

    Recruiting
    • Advanced Hepatocellular Carcinoma (HCC)
    • +2 more
    • Duarte, California
    • +2 more
    Aug 29, 2022

    Hepatocellular Carcinoma Trial in Hershey (Lumason)

    Completed
    • Hepatocellular Carcinoma
    • Hershey, Pennsylvania
      Penn State Hershey Medical Center
    Oct 17, 2022